Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leukemia, Myeloid, Acute × cc-486 × Clear all

Phase

Status

Completed 5 Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

venetoclax 115 Azacitidine 90 Cytarabine 62 fludarabine 41 Specimen Handling 33 Cyclophosphamide 33 Biopsy 24 Decitabine 23 Daunorubicin 23 Idarubicin 21 Granulocyte Colony-Stimulating Factor 18 fludarabine phosphate 17 Injections 17 Whole-Body Irradiation 15 gilteritinib 14 Melphalan 14 Busulfan 13 ivosidenib 11 Stem Cell Transplantation 11 Mycophenolic Acid 11 Gemtuzumab 11 Cladribine 11 CPX-351 11 enasidenib 9 decitabine and cedazuridine drug combination 9 revumenib 8 Tacrolimus 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 tagraxofusp 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022003 2025-03-24

OGILAR

French Innovative Leukemia Organisation

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡